{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:47:47Z","timestamp":1790178467818,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s40263-021-00799-9","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T15:02:45Z","timestamp":1617289365000},"page":"567-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam\u2122 (Monomethyl Fumarate) or Tecfidera\u00ae (Dimethyl Fumarate)"],"prefix":"10.1007","volume":"35","author":[{"given":"Thomas W.","family":"Lategan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurene","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany N.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck S.","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"issue":"12","key":"799_CR1","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","volume":"367","author":"R Gold","year":"2012","unstructured":"Gold R, Kappos L, Arnold D, Bar-Or A, Giovannoni G, Selmaj K, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med. 2012;367(12):1098\u2013107.","journal-title":"N Engl J Med."},{"issue":"12","key":"799_CR2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","volume":"367","author":"R Fox","year":"2012","unstructured":"Fox R, Miller D, Phillips J, Hutchinson M, Havrdova E, Kita M, et al. Placebo controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med. 2012;367(12):1087\u201397.","journal-title":"N Engl J Med."},{"key":"799_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/bdd.364","volume":"24","author":"D Werdenberg","year":"2003","unstructured":"Werdenberg D, Joshi R, Wolffram S, Merkle H, Langguth P. Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. Biopharm Drug Dispos. 2003;24:259\u201373.","journal-title":"Biopharm Drug Dispos."},{"issue":"5","key":"799_CR4","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1172\/JCI72151","volume":"124","author":"H Chen","year":"2014","unstructured":"Chen H, Assmann JC, Krenz A, Rahman M, Grimm M, Christian M, et al. Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate\u2019s protective effect in EAE. J Clin Investig. 2014;124(5):2188\u201392.","journal-title":"J Clin Investig."},{"issue":"2","key":"799_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00401-015-1422-3","volume":"130","author":"B Parodi","year":"2015","unstructured":"Parodi B, Rossi S, Morando S, Cordano C, Bragoni A, Motta C, et al. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. Acta Neuropathol. 2015;130(2):279\u201395.","journal-title":"Acta Neuropathol."},{"key":"799_CR6","unstructured":"Biogen. Tecfidera\u00ae (dimethyl fumarate) prescribing information and patient information. 2020. https:\/\/www.tecfiderahcp.com\/content\/dam\/commercial\/tecfidera\/hcp\/en_us\/pdf\/Tecfidera_PI.pdf. Accessed 22 June 2020."},{"key":"799_CR7","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research. Clinical pharmacology and biopharmaceutics review. 2013. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2013\/204063Orig1s000ClinPharmR.pdf. Accessed 9 July 2020."},{"key":"799_CR8","unstructured":"Banner Life Sciences. Biafertam\u2122 (monomethyl fumarate) prescribing information and patient information. 2020. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a161f9d4-70f1-4097-957a-eafb35d3274f. Accessed 2 Nov 2020."},{"key":"799_CR9","unstructured":"US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry: bioavailability and bioequivalence studies submitted in NDAs or INDs: general considerations (draft March 2014). https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM389370.pdf. Accessed 9 July 2020."},{"issue":"5","key":"799_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF01061471","volume":"20","author":"D Hauschke","year":"1992","unstructured":"Hauschke D, Steinijans VW, Diletti E, Burke M. Sample size determination for bioequivalence assessment using a multiplicative model. J Pharmacokinet Biopharm. 1992;20(5):557\u201361.","journal-title":"J Pharmacokinet Biopharm."},{"key":"799_CR11","doi-asserted-by":"publisher","first-page":"102335","DOI":"10.1016\/j.msard.2020.102335","volume":"45","author":"D Wynn","year":"2020","unstructured":"Wynn D, Lategan TW, Sprague TN, Rousseau FS, Fox EJ. Monomethyl fumarate has better gastrointestinal tolerability profile compared with dimethyl fumarate. Mult Scler Relat Disord. 2020;45:102335. https:\/\/doi.org\/10.1016\/j.msard.2020.102335.","journal-title":"Mult Scler Relat Disord."},{"issue":"2","key":"799_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1352458516649037","volume":"23","author":"R Gold","year":"2017","unstructured":"Gold R, Arnold DL, Bar-Or A, Hutchinson M, Kappos L, Havrdova E, et al. Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study. Mult Scler J. 2017;23(2):253\u201365.","journal-title":"Mult Scler J."},{"key":"799_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7224\/1537-2073.2014-101","volume":"18","author":"EJ Fox","year":"2016","unstructured":"Fox EJ, Vasquez A, Grainger W, Ma TS, von Hehn C, Walsh J, et al. Gastrointestinal tolerability of delayed-release dimethyl fumarate in a multicenter, open-label study of patients with relapsing forms of multiple sclerosis (MANAGE). Int J MS Care. 2016;18:9\u201318.","journal-title":"Int J MS Care."},{"key":"799_CR14","doi-asserted-by":"crossref","unstructured":"McCullough T, Annamalai T, Wustrow D, Cundy K. Comparative gastric irritation of the fumaric acid esters dimethyl fumarate (DMF) and XP23829 in rat and monkey. Neurology. 2013;80(7 Suppl.):P01.159.","DOI":"10.1212\/WNL.80.7_supplement.P01.159"},{"issue":"1","key":"799_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2133.2008.08622.x","volume":"159","author":"T Rantanen","year":"2008","unstructured":"Rantanen T. The cause of the Chinese sofa\/chair dermatitis epidemic is likely to be contact allergy to dimethylfumarate, a novel potent contact sensitizer. Br J Dermatol. 2008;159(1):218\u201321.","journal-title":"Br J Dermatol."},{"issue":"5","key":"799_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1600-0536.2009.01628.x","volume":"61","author":"JF Silvestre","year":"2009","unstructured":"Silvestre JF, Mercader P, De la Cuadra J, Ballester I, Gallardo F, Pujol RM, et al. Shoe contact dermatitis from dimethyl fumarate: clinical manifestations, patch test results, chemical analysis, and source of exposure. Contact Dermatitis. 2009;61(5):249\u201360.","journal-title":"Contact Dermatitis"},{"key":"799_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40263-020-00700-0","volume":"34","author":"RT Naismith","year":"2020","unstructured":"Naismith RT, Wundes A, Ziemssen T, Jasinska E, Freedman MS, Lembo AJ, et al. Diroximel fumarate demonstrates an improved gastrointestinal tolerability profile compared with dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: results from the randomized, double-blind, phase III EVOLVE-MS-2 study. CNS Drugs. 2020;34:185\u201396.","journal-title":"CNS Drugs"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-021-00799-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-021-00799-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-021-00799-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:40:57Z","timestamp":1724740857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-021-00799-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["799"],"URL":"https:\/\/doi.org\/10.1007\/s40263-021-00799-9","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"assertion":[{"value":"19 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported in its entirety by Banner Life Sciences. Banner Life Sciences paid the open access fee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Thomas W. Lategan, Tiffany N. Sprague, and Franck S. Rousseau are employees of Banner Life Sciences. Laurene Wang is a paid consultant to Banner Life Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All pertinent study documents were reviewed, and the study protocol approved by the Chesapeake Institutional Review Board prior to study initiation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All subjects provided written informed consent prior to the conduct of study-related procedures.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This phase I study was retrospectively registered with ClinicalTrials.gov (NCT04570670) on 30 September, 2020.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"TWL: conceptualization, writing, original draft preparation; LW: study design, conduct and oversight, clinical research organization selection, sample size estimation, study result review, and data analysis, interpretation, and presentation; FR: conceptualization, supervision; TNS: project administration. All authors have read, commented on the manuscript, and approved the final manuscript. The authors were responsible for all content and editorial decisions.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}